BUFFALO, N.Y. -- William E. Pelham, Jr., Ph.D., professor of psychology, pediatrics and psychiatry at the University at Buffalo and one of the leading experts in the treatment of attention deficit hyperactivity disorder (ADHD) in children, has received a total of $5.8 million to begin two new studies of treatment approaches for the condition.
The Centers for Disease Control and Prevention have estimated that approximately 4.4 million children in the U.S. between the ages of 4 and 17 have been diagnosed at some point with ADHD.
Results of both studies are expected to help teachers, physicians and families better determine the best treatment plan for each child. Pelham currently is recruiting children in Western New York and Southern Ontario to take part in the studies.
In one study, Pelham, director of the UB Center for Children and Families, will examine the effectiveness of different amounts of behavior modification for young children with ADHD who are not receiving medication at present. Treatment will begin in August and will last for three years.
- The second study will investigate the interactions of medication and behavior modification, and the effect of changes in one intervention on the other's effectiveness and on their combined effectiveness. Children in this study will be involved for one school year, and will enter the study in August 2006, 2007 or 2008.
- The three-year study will involve 150 children who will be in kindergarten or first grade in September 2006 and who meet criteria for ADHD. Because many parents do not know at this young age whether their children have ADHD, children with symptoms of distractibility, impulsivity, difficulty completing tasks and following rules can be referred and will be evaluated for ADHD, Pelham said.
The children will be assigned to one of three groups: a "community comparison group" that receives careful monitoring and medication if needed; a "standard behaviPage: 1 2 3 Related medicine news :1
Contact: Lois Baker
University at Buffalo
. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators2
. Split the difference: Pill-splitting study looks at cost-saving step that could be used by millions3
. FPG receives $8 million for autism research4
. CIRM awards $3.79 million to Burnham Institute5
. The Burroughs Wellcome Fund awards $8 million to infectious disease investigators6
. Scripps Research awarded $17 million for adult stem cell use to treat eye diseases7
. Mayor of New York proposes preventing 100 million deaths from tobacco8
. Menzies School of Health Research receives $5.3 million in Federal Budget9
. $30 million boost to dementia research10
. $1.5 million awarded for palliative care research11
. $7.5 million NIH grant to Yale for Autism Center of Excellence